FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011104073> ?p ?o ?g. }

• W2011104073 endingPage "53" @default.
• W2011104073 startingPage "148" @default.
• W2011104073 abstract "Identification of natural products capable of affording protection against UVB radiation-induced inflammatory responses and generation of oxidative stress may have important human health implications. The UVB exposure-induced skin injury and oxidative stress has been associated with a variety of skin disease conditions including photoaging, inflammation and cancer. Tea is a popular beverage consumed worldwide. In several mouse skin models, topical application as well as oral consumption of green tea has been shown to afford protection against chemical and UVB-induced carcinogenesis and inflammatory responses. In the present study, we investigated in human skin, whether topical application of (-)-epigallocatechin-3-gallate (EGCG), the major polyphenolic constituent in green tea, inhibits UVB-induced infiltration of leukocytes (macrophage/neutrophils), a potential source of generation of reactive oxygen species (ROS), and generation of prostaglandin (PG) metabolites. Human subjects were UVB irradiated on sun-protected skin to four times their minimal erythema dosage (MED) and skin biopsies or keratomes were obtained either 24 h or 48 h later. We found that topical application of EGCG (3 mg/2.5 cm2) before UVB (4 MED) exposure to human skin significantly blocked UVB-induced infiltration of leukocytes and reduced myeloperoxidase activity. These infiltrating leukocytes are considered to be the major source of generation of ROS. In the same set of experiments we found that topical application of EGCG before UVB exposure decreased UVB-induced erythema. In additional experiments, we found that microsomes from EGCG pretreated human skin and exposed to UVB, compared to UVB exposure alone, produced significantly reduced PG metabolites, particularly PGE2. The PG metabolites play a critical role in free radical generation and skin tumor promotion in multistage skin carcinogenesis. Careful microscopic examination of skin sections, stained with hematoxylin and eosin, under higher magnification (x400) also revealed that EGCG pretreated and UVB-exposed human skin contained fewer dead cells in the epidermis with comparison to nonpretreated UVB-exposed skin. Taken together, our data demonstrate that EGCG has the potential to block the UVB-induced infiltration of leukocytes and the subsequent generation of ROS in human skin. This may explain the possible mechanism involved in anti-inflammatory effects of green tea. We suggest that EGCG may be useful as a topical agent for protection against UVB-induced ROS-associated inflammatory dermatoses, photoaging and photocarcinogenesis. Further studies are warranted in this direction." @default.
• W2011104073 created "2016-06-24" @default.
• W2011104073 creator A5036743590 @default.
• W2011104073 creator A5051982352 @default.
• W2011104073 creator A5077865685 @default.
• W2011104073 creator A5082425428 @default.
• W2011104073 date "1999-02-01" @default.
• W2011104073 modified "2023-09-24" @default.
• W2011104073 title "Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin." @default.
• W2011104073 cites W1501564271 @default.
• W2011104073 cites W1607772536 @default.
• W2011104073 cites W187390374 @default.
• W2011104073 cites W1907068960 @default.
• W2011104073 cites W1967401562 @default.
• W2011104073 cites W1975943298 @default.
• W2011104073 cites W1993358791 @default.
• W2011104073 cites W2006502914 @default.
• W2011104073 cites W2007140957 @default.
• W2011104073 cites W2020358486 @default.
• W2011104073 cites W2023107758 @default.
• W2011104073 cites W2023518603 @default.
• W2011104073 cites W2036154499 @default.
• W2011104073 cites W2036352133 @default.
• W2011104073 cites W2039498286 @default.
• W2011104073 cites W2040528315 @default.
• W2011104073 cites W2043707891 @default.
• W2011104073 cites W2055986548 @default.
• W2011104073 cites W2060085801 @default.
• W2011104073 cites W2065342114 @default.
• W2011104073 cites W2067129191 @default.
• W2011104073 cites W2072727557 @default.
• W2011104073 cites W2076429988 @default.
• W2011104073 cites W2076438363 @default.
• W2011104073 cites W2079179493 @default.
• W2011104073 cites W2082851306 @default.
• W2011104073 cites W2087075582 @default.
• W2011104073 cites W2124690619 @default.
• W2011104073 cites W2127735574 @default.
• W2011104073 cites W2147231692 @default.
• W2011104073 cites W2165382073 @default.
• W2011104073 cites W2409789639 @default.
• W2011104073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10048310" @default.
• W2011104073 hasPublicationYear "1999" @default.
• W2011104073 type Work @default.
• W2011104073 sameAs 2011104073 @default.
• W2011104073 citedByCount "68" @default.
• W2011104073 countsByYear W20111040732012 @default.
• W2011104073 countsByYear W20111040732013 @default.
• W2011104073 countsByYear W20111040732014 @default.
• W2011104073 countsByYear W20111040732015 @default.
• W2011104073 countsByYear W20111040732016 @default.
• W2011104073 countsByYear W20111040732017 @default.
• W2011104073 countsByYear W20111040732018 @default.
• W2011104073 countsByYear W20111040732019 @default.
• W2011104073 countsByYear W20111040732020 @default.
• W2011104073 countsByYear W20111040732021 @default.
• W2011104073 countsByYear W20111040732022 @default.
• W2011104073 crossrefType "journal-article" @default.
• W2011104073 hasAuthorship W2011104073A5036743590 @default.
• W2011104073 hasAuthorship W2011104073A5051982352 @default.
• W2011104073 hasAuthorship W2011104073A5077865685 @default.
• W2011104073 hasAuthorship W2011104073A5082425428 @default.
• W2011104073 hasConcept C121332964 @default.
• W2011104073 hasConcept C121608353 @default.
• W2011104073 hasConcept C126322002 @default.
• W2011104073 hasConcept C153400128 @default.
• W2011104073 hasConcept C16005928 @default.
• W2011104073 hasConcept C185592680 @default.
• W2011104073 hasConcept C203014093 @default.
• W2011104073 hasConcept C2776151105 @default.
• W2011104073 hasConcept C2776914184 @default.
• W2011104073 hasConcept C2776960578 @default.
• W2011104073 hasConcept C2777192995 @default.
• W2011104073 hasConcept C2777459323 @default.
• W2011104073 hasConcept C2777789703 @default.
• W2011104073 hasConcept C2777926168 @default.
• W2011104073 hasConcept C2778004101 @default.
• W2011104073 hasConcept C2779121184 @default.
• W2011104073 hasConcept C2909910311 @default.
• W2011104073 hasConcept C2992814287 @default.
• W2011104073 hasConcept C31903555 @default.
• W2011104073 hasConcept C48349386 @default.
• W2011104073 hasConcept C54355233 @default.
• W2011104073 hasConcept C55493867 @default.
• W2011104073 hasConcept C70899900 @default.
• W2011104073 hasConcept C71924100 @default.
• W2011104073 hasConcept C86803240 @default.
• W2011104073 hasConcept C97355855 @default.
• W2011104073 hasConcept C98274493 @default.
• W2011104073 hasConceptScore W2011104073C121332964 @default.
• W2011104073 hasConceptScore W2011104073C121608353 @default.
• W2011104073 hasConceptScore W2011104073C126322002 @default.
• W2011104073 hasConceptScore W2011104073C153400128 @default.
• W2011104073 hasConceptScore W2011104073C16005928 @default.
• W2011104073 hasConceptScore W2011104073C185592680 @default.
• W2011104073 hasConceptScore W2011104073C203014093 @default.
• W2011104073 hasConceptScore W2011104073C2776151105 @default.
• W2011104073 hasConceptScore W2011104073C2776914184 @default.

• next